What Happened?
Seattle, WA-based Adaptive-Biotechnologies Promoted Kyle Piskel as Interim Chief Financial Officer
About the Company
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people`s lives by learning from the wisdom of their adaptive immune systems. Adaptive`s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated.
About the Person
Kyle Piskel is Interim Chief Financial Officer at Adaptive Biotechnologies. Previously, Kyle held various senior HR leadership roles in the industry.
Info Source
News
Short Profile